The Hungarian-American billionaire George Soros is about to invest in the Walloon biotech company Univercells. De Tijd and L’Echo learned that. Bill Gates is already in the capital.
Univercells refueled 50 million euros two months ago. Of this, 15 million came from Adjuvant Capital, a fund of Microsoft founder Bill Gates, who has already invested a total of 45 million in Univercells.
This capital round seems to be followed today by a second round of 20 to 25 million euros. The signatures are not yet on paper, but the completion is in sight, it is said. One name stands out among these new investors: the Economic Development Fund of financier and top investor George Soros. Univercells declined to comment on the information.
The Walloon company manufactures “bioreactors” to produce vaccines and medicines in a small production environment on a small scale, cheaply and on a large scale. This allows Univercells to make as many vaccines as the major players in the industry, but at a much cheaper price.
The company from Gosselies is running projects for vaccines against polio, measles, rubella and rabies. It also cooperates with some manufacturers of a Covid vaccine, such as the Italian ReiThera and the German Leukocare. If everything goes smoothly, Univercells can start large-scale production in the first half of 2021. New production lines are being built for this. The company employs around 200 people.